Pfizer’s Exit Halves Japan Biotech Firm Value In Three Days
Sosei Group Corp. has lost over half of its market value in just three days on concern about its outlook after Pfizer Inc. said Monday it will discontinue the partnered development of a diabetes and obesity drug. • None UBS Preparing to Cut Over Half of Credit Suisse Workforce Shares of the…
#soseigroupcorp #pfizerinc #noneubs #tokyo #pfizer #glp1 #citigroup #hidemaruyamaguchi